Repository of Research and Investigative Information

Repository of Research and Investigative Information

Shahid Sadoughi University of Medical Sciences

Synthesis of aurone sulfonate derivatives: Evaluation of their cholinesterase inhibition, neuroprotective effects, and expression of oxidative stress-related genes

(2023) Synthesis of aurone sulfonate derivatives: Evaluation of their cholinesterase inhibition, neuroprotective effects, and expression of oxidative stress-related genes. Journal of Molecular Structure. p. 12. ISSN 0022-2860

Full text not available from this repository.

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

A set of novel aurone derivatives, designed as A0 -A7 and B1-B4, were synthesized to serve as acetylcholinesterase inhibitors. The Ellman's colorimetric method was utilized to measure the anticholinesterase activity of the synthesized compounds. The derivatives were then tested on human SH-SY5Y cells under an oxidative stress model induced by hydrogen peroxide (H2O2). Effects on cell viability, ROS levels, protein carbonyl content, and gene expression of NRF2 and phase II anti-oxidative enzymes were measured after 24 h. The study revealed that a most compounds demonstrated anti-acetylcholinesterase (AChE) activity within the micromolar or submicromolar range. Compound A4 exhibited the highest activity level with an IC50 value of 0.04 mu M, among the compounds tested. Additionally, compound A2 protected SH-SY5Y cells from oxidative stress by elevating NRF2 gene expression.

Item Type: Article
Keywords: Aurone sulfonate derivatives Acetylcholinesterase Nrf2 NQO1 GSTK1 SH-SY5Y cell line multifunctional agents acetylcholinesterase disease design nrf2 Chemistry
Page Range: p. 12
Journal or Publication Title: Journal of Molecular Structure
Journal Index: WoS
Volume: 1294
Identification Number: https://doi.org/10.1016/j.molstruc.2023.136334
ISSN: 0022-2860
Depositing User: Mr mahdi sharifi
URI: http://eprints.ssu.ac.ir/id/eprint/28987

Actions (login required)

View Item View Item